fashion -WSS

fashion

author：comprehensive 2025-09-06 04:38:22 - browse：8252

In the center, three researchers examine a DNA helix. Two people stand in the front, one puts an apple into a capsule containing vegetables, the other holds a check list while standing next to a pile of medicines. On the right side, a scientist injects into mitochondria while another takes notes. A person behind the duo looks at a projection of a brain. On the left side, a client looks at a heart projection from a device held by a robot — biotech coverage from STAT — Adobe

When it comes to bringing an experimental drug to market and selling it, Novo Nordisk, the maker of the weight loss drug Wegovy, is tops, according to a new analysis.

But if you want to invent lots of potential drugs that could eventually reach the market, you’d be far better off with Johnson & Johnson, Merck, or AstraZeneca.

The analysis, the 13th edition of the Pharmaceutical Innovation and Invention Index, was produced by the consultancy Idea Pharma and released Thursday at the STAT Breakthrough Summit in San Francisco.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Chinese researcher claims birth of first gene

entertainment

WSS

Erich Jarvis studies song birds to learn about human stuttering

Erich Jarvis studies song birds to learn about human stuttering

Steward Health Care expansion into Malta flopped

VC firm General Catalyst wants to buy a health system

Yancopoulos of Regeneron works to expand Dupixent success

AI can decode, harness the power of the humane immune system

leisure time

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

focus

Alkermes shareholders re

A Q&A with the global head of Boehringer Ingelheim's innovation unit

The high cost of giving birth even with insurance

FDA rejects Alnylam's heart disease treatment over insufficient data

Psychedelics group wrestles with new pharma identity

With Wegovy coverage, Medicare patients may face high costs

Drug repurposing or repositioning? The language matters

When women are denied an abortion, their children fare worse than peers

Trump demands the U.S. pay no more for drugs than other countries … again

3 questions for the future of Biden's cancer moonshot

hotspot

Pregnancy ages women, but effects reverse after delivery

Biotech investment managers search for lucrative opportunities

When women are denied an abortion, their children fare worse than peers

U.K. officials, researchers try to ease path for bespoke genetic treatments

Erich Jarvis studies song birds to learn about human stuttering

Phenylephrine and the overlooked value of the placebo effect

focus

hotspot

entertainment

leisure time